fda ban on compounded semaglutide & Tirzepatide 2025: Safe Use Guide FDA crackdown on off-brand Ozempic

As of mid-2025, retatrutide remains in clinical trials and has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)

Butaphosphan + Vitamin B12 Injection BuVitBCare Dosage Packaging What is Butaphosphan + Vitamin B12

PMID 38629387

This additional glucagon component theoretically amplifies energy expenditure effects beyond what dual agonism alone can produce

However, they come with potential side effects such as a slight increase in resting heart rate, risks for heart failure in certain groups, and complications for individuals with diabetic retinopathy